PMDA

Ryosuke Kuribayashi1,2, Aya Hariu3, Ayuki Nakano3

  • 1Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp.

PubMed
概括

日本生物类似药的批准依赖于临床研究,如药理动力学 (PK) 和疗效试验. 样本大小各不相同,有效性研究通常需要更大的患者队列,特别是在瘤学和风湿病学中.